Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia. 1997

K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009460 Neurologic Examination Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system. Examination, Neurologic,Neurological Examination,Examination, Neurological,Examinations, Neurologic,Examinations, Neurological,Neurologic Examinations,Neurological Examinations
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
December 1992, Archives of general psychiatry,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
January 1991, Biological psychiatry,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
October 1991, Archives of general psychiatry,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
March 1988, Psychiatry research,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
April 1995, American journal of medical genetics,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
January 2001, Journal of psychiatric research,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
November 1994, Biological psychiatry,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
February 1992, Biological psychiatry,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
March 2000, Biological psychiatry,
K Yamada, and S Kanba, and K Ohnishi, and I Ashikari, and G Yagi, and M Asai
August 1995, Biological psychiatry,
Copied contents to your clipboard!